Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

Barclays analyst Gena Wang raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $435 from $418 and keeps an Equal Weight rating ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $440.68, marking a -0.72% move from the previous day. Vertex (VRTX) has received quite a bit of attention from Zacks.com ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

The minimum point is the minimum y value that the parabola reaches. The maximum point is the maximum y value that the parabola reaches. The symmetry of the parabola is created because each x value ...

As you prepare for JEE 2025, revising important formulas is crucial to performing well in the exam. The JEE syllabus covers a vast array of topics in Physics, Chemistry, and Mathematics, and being ...

It's one of those things most people remember from their school days. The angles in a triangle always add up to 180˚. And a right-angled triangle always has one angle that is 90°, so the other ...